A recent study analyzed 369 children (aged 0–17 years) diagnosed with new-onset AML, looking into the frequency of ASXL1 and ASXL2 mutations, associated clinical features, and correlation with other genetic changes. This evidence concerns the gene ASXL1 and acute myeloid leukemia.